568
Participants
Start Date
July 1, 2021
Primary Completion Date
June 24, 2022
Study Completion Date
June 29, 2027
Yellow fever vaccine (produced on serum-free Vero cells)
Powder and diluent for suspension for injection Subcutaneous injection
Yellow fever vaccine
Powder and diluent for suspension for injection Subcutaneous injection
New York University Langone Medical Center Site Number : 8400013, New York
SUNY Upstate Medical University Global Health Institute Site Number : 8400006, East Syracuse
Rochester Clinical Research, Inc.- Site Number : 8400010, Rochester
Johns Hopkins Bloomberg School of Public Health (JHSPH)- Site Number : 8400004, Baltimore
Emory University Decatur- Site Number : 8400005, Decatur
Saint Louis University- Site Number : 8400003, St Louis
Velocity Clinical Research- New Orleans Site Number : 8400008, New Orleans
J Lewis Research Inc- Site Number : 8400012, Salt Lake City
Meridian Clinical Research- Site Number : 8400009, Omaha
Harvard University Medical School- Site Number : 8400002, Boston
Velocity Clinical Research - Providence Site Number : 8400015, East Greenwich
Sanofi Pasteur, a Sanofi Company
INDUSTRY